ABVC BioPharma, Inc. Increase (Decrease) in Deferred Income Taxes
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Deferred Income Taxes of $256.73 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2022-11-14
- ABVC BioPharma, Inc. increase (decrease) in deferred income taxes for the quarter ending 2021-09-30 was $132.33K.
- ABVC BioPharma, Inc. increase (decrease) in deferred income taxes for the quarter ending 2021-06-30 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in deferred income taxes for the quarter ending 2021-03-31 was $124.40K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month |
|---|---|---|---|
| 2021-09-30 | $132.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $132.33K derived: sum of 2 quarters · filed 2022-11-14 | $256.73K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $124.40K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $124.40K 10-Q · filed 2022-05-16 |